483
Pillar5 Pharma Inc.Pillar5 Pharma Inc. – FDA 483, Feb 7, 2025
Record Details
Pillar5 Pharma Inc., a contract manufacturer in Arnprior, was cited for significant deficiencies in its aseptic processing, quality control, and laboratory operations. The inspection revealed inadequate validation of aseptic processes, poor disinfectant efficacy studies, and failures in thoroughly investigating discrepancies and maintaining stability programs. These issues raise concerns about the sterility assurance and overall quality of drug products manufactured by the firm.
View Company Profile
ID · aae128df-7323-4546-9ab7-cb02e0d26682
Other documents for Pillar5 Pharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.